Inhaled aztreonam lysine in the management of Pseudomonas aeruginosa in patients with cystic fibrosis: real-life effectiveness

Autores de IIS La Fe

• Emilio Monte Boquet

  Autor

Participantes ajenos a IIS La Fe

• Jiménez-Lozano I.
• Luna-Paredes C.
• Fernández-Polo A.
• Cañete-Ramírez C.
• Roch-Santed M.
• Gartner S.
• Álvarez-Fernández A.

Grupos

• Grupo de Investigación de Farmacia

Abstract

Abstract no disponible

Keywords

• amikacin; aztreonam lysine; ceftazidime; colistin; tobramycin; adult; adverse drug reaction; anthropometric parameters; antibiotic therapy; arthralgia; Article; bacterial colonization; body height; body mass; body weight; child; chronic infection; cohort analysis; coughing; cystic fibrosis; disease exacerbation; drug efficacy; drug safety; drug tolerability; drug withdrawal; female; follow up; forced expiratory volume; gene mutation; genotype; hemoptysis; hospital admission; hospitalization; human; hypotension; lung function; major clinical study; male; medical record; multicenter study; observational study; patient selection; prescription; Pseudomonas aeruginosa; Pseudomonas infection; respiratory tract disease; retrospective study; skin irritation